Coronavirus News Roundup: Johnson & Johnson Submits EUA for COVID-19 Vaccine Candidate, Poll Finds Americans Dissatisfied With Vaccine Rollout
Here's the roundup of the latest coronavirus-related news.
The coronavirus disease 2019 (COVID-19) vaccination effort is well underway in the US, with over 46.4 million administered doses and 11 million Americans fully vaccinated against the virus as of press time. This week, Johnson & Johnson submitted an emergency use authorization (EUA) for its COVID-19 investigational vaccine, and a new Gallup poll reported many Americans being dissatisfied with the vaccine rollout.
Here’s a roundup of the latest coronavirus-related news:
Gallup Poll: Many Americans Dissatisfied With COVID-19 Vaccine Rollout
Nearly two-thirds of Americans are not satisfied with the rollout of the COVID-19 vaccine in the United States, according to results of a new Gallup poll.
FDA Authorizes Bamlanivimab-Etesevimab Combination Treatment for COVID-19
Officials with the FDA have issued an EUA to Eli Lilly for the combination treatment of bamlanivimab and etesevimab for mild-to-moderate COVID-19 in adult and pediatric patients at high risk for severe infection.
AHA Urges Americans With Heart Disease to Receive COVID-19 Vaccines
The American Heart Association (AHA) is urging all Americans—but particularly those with heart conditions or who are at risk for cardiovascular disease—to receive the COVID-19 vaccine.
Johnson & Johnson Submits EUA for COVID-19 Vaccine Candidate
Johnson & Johnson has submitted an EUA to the FDA for its single-dose vaccine candidate for COVID-19.
Pharmacy Students Administer COVID-19 Vaccines
Drug Topics interviewed Karen Mackinnon and Sara Revolinski from the Medical College of Wisconsin School of Pharmacy about how their pharmacy students have been rising to meet the demand of the pandemic by administering COVID-19 vaccines.
